These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 29987852

  • 1. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J.
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [Abstract] [Full Text] [Related]

  • 2. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L, Lv J, Zhang Y, Li J, Wang Y, Yang H.
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B, Li M, Zhang L, Huang M, Lei JB, Fu GH, Liu CX, Lai QW, Chen QQ, Wang YL.
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH, Yang LB, Geng XL, Wang R, Zhang ZC.
    Int J Clin Exp Pathol; 2015 Apr; 8(3):2994-3000. PubMed ID: 26045809
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ, Guo XJ, Zhao YM, Fang Y.
    Int J Clin Exp Pathol; 2015 Apr; 8(11):15138-42. PubMed ID: 26823857
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z.
    Cancer Biomark; 2018 Apr; 23(4):589-601. PubMed ID: 30475755
    [Abstract] [Full Text] [Related]

  • 7. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S, Li W, Guo A.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30944201
    [Abstract] [Full Text] [Related]

  • 8. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF, Dai ZT, Liu WD, Zhao ZX, Kong YH.
    Eur Rev Med Pharmacol Sci; 2019 Feb 30; 23(4):1428-1433. PubMed ID: 30840263
    [Abstract] [Full Text] [Related]

  • 9. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct 30; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB, Wang JA, Lv RQ.
    Eur Rev Med Pharmacol Sci; 2019 Feb 30; 23(4):1418-1427. PubMed ID: 30840262
    [Abstract] [Full Text] [Related]

  • 11. The biological function of long noncoding RNA FAL1 in oesophageal carcinoma cells.
    Yang Z, Liu D, Wu D, Liu F, Liu C.
    Artif Cells Nanomed Biotechnol; 2019 Dec 30; 47(1):896-903. PubMed ID: 30873881
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z, Tan M, Chen G, Li Z, Lu X.
    IUBMB Life; 2017 Nov 30; 69(11):867-876. PubMed ID: 28960757
    [Abstract] [Full Text] [Related]

  • 13. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.
    Zhang J, Ju C, Zhang W, Xie L.
    IUBMB Life; 2018 Nov 30; 70(11):1115-1121. PubMed ID: 30120876
    [Abstract] [Full Text] [Related]

  • 14. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H, Zhao L.
    J Cell Biochem; 2019 Apr 30; 120(4):6502-6514. PubMed ID: 30485482
    [Abstract] [Full Text] [Related]

  • 15. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K, Wang J, Xu J, Chen L, Chen Y.
    Cell Physiol Biochem; 2017 Apr 30; 43(1):339-352. PubMed ID: 28854421
    [Abstract] [Full Text] [Related]

  • 16. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
    Qu G, Ma Z, Tong W, Yang J.
    Mol Med Rep; 2018 Jul 30; 18(1):779-788. PubMed ID: 29845204
    [Abstract] [Full Text] [Related]

  • 17. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y, Zhao F, Zhang Z, Sun F, Wang M.
    Cancer Biother Radiopharm; 2018 Nov 30; 33(9):365-372. PubMed ID: 29989838
    [Abstract] [Full Text] [Related]

  • 18. CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition.
    Luo Y, Tao H, Jin L, Xiang W, Guo W.
    Cancer Biother Radiopharm; 2020 Feb 30; 35(1):58-65. PubMed ID: 31724892
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H, Lin J, Yao X, Li Y, Lin X, Lu H.
    Cell Physiol Biochem; 2018 Feb 30; 45(5):1904-1914. PubMed ID: 29518771
    [Abstract] [Full Text] [Related]

  • 20. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R, Zhao XL.
    Eur Rev Med Pharmacol Sci; 2018 May 30; 22(10):2978-2984. PubMed ID: 29863240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.